MD, Chief Physician; He obtained his Doctorate in Oncology from Peking University Cancer Hospital in 2006, and completed post‑doctoral research at the Duke Cancer Center in the United States from December 2006 to February 2008. He has been engaged in clinical work in medical oncology for more than 20 years, with a specialty in standardized diagnosis, treatment and translational research of malignant lymphomas. He has extensive experience in comprehensive therapy and cellular immunotherapy for malignant lymphomas, and has participated in multiple domestic and international clinical trials of new drugs in the field of lymphoma.
English